MBIOSEQ Trademark Application Published for Opposition
Summary
The USPTO has published the trademark application for MBIOSEQ for opposition. The application covers reagents, assays, software, and instruments related to medical diagnostics, molecular biology, and laboratory testing. The filing date was November 18, 2025.
What changed
The United States Patent and Trademark Office (USPTO) has published the trademark application for 'MBIOSEQ' for a 30-day opposition period. The application, filed on November 18, 2025, seeks to register trademarks for a range of goods and services including diagnostic and chemical reagents for medical, veterinary, and research purposes, software for laboratory apparatus and bioinformatics analysis, laboratory apparatus, medical instruments, and services related to the identification and characterization of biological substances.
This publication signifies that the trademark has passed initial examination and is now open for challenges from third parties who believe they may be harmed by the registration. Companies operating in the pharmaceutical, biotechnology, and medical device sectors should monitor this application if they have similar existing trademarks or are planning to launch products under a similar name. No immediate compliance actions are required for entities other than potential opposers, but awareness of this pending registration is advisable for strategic branding and intellectual property management.
Source document (simplified)
← USPTO Trademark Applications
MBIOSEQ
Published for Opposition TM79440054 Kind: published Mar 26, 2026
Abstract
Reagents and assays for medical purposes; diagnostic reagents and assays for medical use; chemical reagents for molecular biology, for medical or veterinary use; chemical reagents and assays for use in medical and veterinary testing, for detecting genetic mutations.; Downloadable and recorded computer software for laboratory apparatus, other than for medical use; downloadable and recorded computer software for processing, evaluating and displaying measurement data from a laboratory apparatus; downloadable and recorded software for bioinformatics analysis, genomic data interpretation, and drug resistance profiling; laboratory apparatus, other than for medical use; laboratory apparatus, other than for medical use, for the collection, sequencing, application, and transfer of microbial and non-microbial preparations.; Medical instruments; instruments for carrying-out diagnostic tests for medical purposes; laboratory instruments for medical use; laboratory instruments for medical use for collection, sequencing, application, and transfer of microbial and non-microbial preparations; medical instruments for use in molecular diagnostics.; Reagents and assays for research purposes; diagnostic reagents and assays for scientific use; chemical reagents and assays for molecular biology, other than for medical or veterinary use; chemical reagents and assays for use in genetic research, for detecting genetic mutations.; Natural science and technical services for identifying and characterizing substances, in particular measurement of biological samples and evaluating measurement data of biological samples; design and development of computer software for use in molecular diagnostics.
Filing Date
2025-11-18
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: Trademarks - Pharmaceuticals (Class 005) publishes new changes.